Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357496 (US10214519, Example 240) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357571 (US10214519, Example 332) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357597 (US10214519, Example 360 | US10214519, Example 361) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357385 (US10214519, Example 111) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357480 (US10214519, Example 224) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357302 (US10214519, Example 28) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357275 (US10214519, Example 1) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357529 (US10214519, Example 285) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357494 (US10214519, Example 238) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357522 (US10214519, Example 278) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357362 (US10214519, Example 88) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357575 (US10214519, Example 336) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357485 (US10214519, Example 229) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357486 (US10214519, Example 230 | US10214519, Example 356 ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357532 (US10214519, Example 288) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357569 (US10214519, Example 330) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357492 (US10214519, Example 236) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357581 (US10214519, Example 344 | US10214519, Example 345) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357530 (US10214519, Example 286 | US10214519, Example 342 ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357482 (US10214519, Example 226) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357538 (US10214519, Example 294) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357552 (US10214519, Example 308) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357456 (US10214519, Example 200 | US10214519, Example 340 ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357369 (US10214519, Example 95) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357609 (US10214519, Example 372 | US10214519, Example 373) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357498 (US10214519, Example 242) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357524 (US10214519, Example 280 | US10214519, Example 346 ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357589 (US10214519, Example 352 | US10214519, Example 353) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357303 (US10214519, Example 29) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357375 (US10214519, Example 101) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357486 (US10214519, Example 230 | US10214519, Example 356 ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357440 (US10214519, Example 170) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357568 (US10214519, Example 329) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357570 (US10214519, Example 331) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357476 (US10214519, Example 220) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357591 (US10214519, Example 354 | US10214519, Example 355) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357342 (US10214519, Example 68) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357489 (US10214519, Example 233) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357460 (US10214519, Example 204) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357475 (US10214519, Example 219) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357616 (US10214519, Example 379) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357304 (US10214519, Example 30) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357551 (US10214519, Example 307) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357356 (US10214519, Example 82) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357456 (US10214519, Example 200 | US10214519, Example 340 ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357500 (US10214519, Example 244) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357479 (US10214519, Example 223) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357306 (US10214519, Example 32) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357626 (US10214519, Example 392) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM357305 (US10214519, Example 31) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were pu... | US Patent US10214519 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Displayed 1 to 50 (of 354 total ) | Next | Last >> |
